Global Big Pharma, Big Dividends

Jiangsu Nhwa Pharmaceutical

Market Cap: CN¥27.6b

Engages in production, marketing, and services related to central nervous system drugs in China.

Zhejiang Wolwo Bio-Pharmaceutical

Market Cap: CN¥15.3b

A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.

Orion Oyj

Market Cap: €9.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Eisai

Market Cap: JP¥1.4t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Ipsen

Market Cap: €9.5b

Operates as a biopharmaceutical company worldwide.

Apeloa PharmaceuticalLtd

Market Cap: CN¥18.8b

Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.

Yunnan Baiyao GroupLtd

Market Cap: CN¥101.3b

Engages in the pharmaceutical business in China.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, sells, and import/export of pharmaceuticals products worldwide.

Ajanta Pharma

Market Cap: ₹299.5b

A pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages.

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥28.8b

Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.

Zoetis

Market Cap: US$65.1b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Dong-E-E-JiaoLtd

Market Cap: CN¥30.5b

Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.

CSPC Pharmaceutical Group

Market Cap: HK$110.3b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹264.5b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Lupin

Market Cap: ₹905.2b

Operates as a pharmaceutical company in India, the United States, and internationally.

Zydus Lifesciences

Market Cap: ₹997.3b

Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

Changchun High-Tech Industry (Group)

Market Cap: CN¥52.4b

Researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China.

Shenzhen Hepalink Pharmaceutical Group

Market Cap: CN¥16.0b

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Tibet Cheezheng Tibetan Medicine

Market Cap: CN¥14.9b

Tibet Cheezheng Tibetan Medicine Co., Ltd.

Novo Nordisk

Market Cap: DKK 1.6t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

China Resources Double-Crane PharmaceuticalLtd

Market Cap: CN¥19.2b

China Resources Double-Crane Pharmaceutical Co.,Ltd.

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥118.7b

Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.

Ipca Laboratories

Market Cap: ₹336.7b

An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.9b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Jilin Aodong Pharmaceutical Group

Market Cap: CN¥23.5b

Jilin Aodong Pharmaceutical Group Co., Ltd.

Pfizer

Market Cap: ₹235.6b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

Torrent Pharmaceuticals

Market Cap: ₹1.2t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Zhejiang Huahai Pharmaceutical

Market Cap: CN¥31.6b

Operates as a pharmaceutical company in China and internationally.

Royalty Pharma

Market Cap: US$21.2b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

H. Lundbeck

Market Cap: DKK 42.7b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Viatris

Market Cap: US$11.8b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

GSK

Market Cap: UK£66.3b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

AstraZeneca

Market Cap: UK£193.1b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Aurobindo Pharma

Market Cap: ₹630.8b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

Shandong Buchang Pharmaceuticals

Market Cap: CN¥19.1b

Shandong Buchang Pharmaceuticals Co., Ltd.

Haisco Pharmaceutical Group

Market Cap: CN¥59.3b

Researches, develops, manufactures, and sells pharmaceutical products in China.